Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis. Our proprietary pan-amyloid removal (PAR) therapeutics are designed to directly bind to and remove toxic amyloid in organs and tissues. By targeting the universal disease-causing pathology in all systemic amyloidosis diseases, PAR therapeutics have the potential to treat and reverse disease in patients with all types and stages of systemic amyloidosis.
| Website | https://www.attralus.com/ |
| Employees | 20 (15 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Clinical Stage Drug Development, Biopharmaceutical Research, Pharmaceutical Development, Novel Therapeutics, Drug Discovery Platform, Targeted Therapies, Translational Research, Clinical Trials, Precision Medicine, Drug Candidates, Protein Aggregation, Biotechnology, New Drug Applications, Therapeutic Antibodies |
| Competitors | AbbVie, Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb, Genentech, Amgen, Regeneron, Lilly India +37 more (view full list) |
Looking for a particular Attralus employee's phone or email?
Attralus Questions
Mark Timney is the CEO and Board Member, Attralus Therapeutics of Attralus.
15 people are employed at Attralus.
Attralus is based in Naples, Florida.
Top Attralus Employees
-
35
-
Glen Firestone
President at Attralus
Philadelphia, PA, US25 -
Gregory Bell
Chief Medical Officer at Attralus
Tiburon, CA, US25 -
32
-
James Testa
Vice President Finance at Attralus
Mahwah, NJ, US21 -
Christine Huh
Head of Human Resources at Attralus
United States25+ -
Nicolas Angell
Executive Director, Analytical and Formulation Development at Attralus
California, United States12 -
Stephanie Beighley
Head of IT Operations at Attralus
New York, NY, US33
Related Companies
